TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies April 30, 2010